AMA and AAP's vaccine stance linked to pharmaceutical funding ties
The American Medical Association and the American Academy of Pediatrics criticized President Trump's vaccine order while both organizations receive substantial revenue from drug makers.
President Donald Trump's executive order trimmed the list of mandatory childhood vaccines, eliminating recommendations for COVID-19 and flu shots. In response, the American Medical Association released a press statement asserting that altering the established schedule could weaken public confidence and harm children, with President Willie Underwood III highlighting the need for evidence-based decisions. The American Academy of Pediatrics also condemned the order, citing a surge in measles cases and the upcoming flu season.
Critics note that the AMA profits from selling physician data to drug firms and has historically received millions from companies like Pfizer and Purdue Pharma, while the AAP hosts costly donor summits featuring major vaccine manufacturers. These financial connections suggest a potential conflict between the groups' public health messaging and industry interests.
Why it matters
Financial ties may bias medical groups' vaccine recommendations, affecting public health policy.
In this story